Nika Pharmaceuticals Inc NIKA
$0.42
Last Updated: Aug 19, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
NIKA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Nika Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Nika Pharmaceuticals Inc. Stock Analysis NIKA
United States Health Care Small Cap Nika Pharmaceuticals, Inc. engages in the development and distribution of a variety of pharmaceutical products, including dietary supplements and antiviral drugs. The company is headquartered in Henderson, Nevada and currently employs 0 full-time employees. The company went IPO on 2024-01-24. The company has the exclusive rights agreement for the production and distribution of two dietary supplements, namely Carotilen and Physiolong. Carotilen is a dietary supplement in the form of soft gelatin capsules that improves and regulates the metabolism of the epithelial cells and protects them from degenerative alterations. Physiolong is a dietary food supplement in the form of hard gelatin capsules, which serves as a general stimulant for those in a period of convalescence, as well as in situations of high mental and physical loads. The company has an exclusive rights agreement for the production and distribution of Thymus Nuclear Glycoprotein (TNG). The company also has the rights agreement for the production and sale of an additional six dietary supplements, such as Hypocholestin, Biodetoxin, Dry Boza, Fructin, Anthocylen C, and Silymaron.
Nika Pharmaceuticals Inc (NIKA) Chart
Financial Metrics & Statements of Nika Pharmaceuticals Inc (NIKA)
FAQ's for Nika Pharmaceuticals Inc (NIKA)
- As of August 2026, Nika Pharmaceuticals Inc NIKA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Nika Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Nika Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Nika Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Nika Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Nika Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Nika Pharmaceuticals Inc (NIKA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
